- IFF Pharma Solutions to participate in Excipient World 2025 with a focus on sustainability and innovation.
- Key offerings include METHOCEL™, ETHOCEL™, and POLYOX™, alongside newly introduced low nitrite solutions.
- Dr. Anne Adden to present "Sustainable by Design: The Future of Excipients" on May 13.
IFF Pharma Solutions, a division of International Flavors & Fragrances Inc. (IFF, Financial), is set to highlight its innovations in sustainable excipient solutions at Excipient World 2025. The event takes place from May 13-14 at the Gaylord National Resort and Convention Center, National Harbor, Maryland.
Booth 205 will showcase IFF's sustainable innovations, including controlled-release formulations and solutions for mitigating nitrosamine risks. Among the featured products are the METHOCEL™, ETHOCEL™, and POLYOX™ lines, as well as the newly developed Low Nitrite METHOCEL™ hydroxypropyl methylcellulose (HPMC) and Avicel®PH LN.
In addition to the product showcase, Dr. Anne Adden, global strategic marketing director for sustainability and dietary supplements at IFF, will present "Sustainable by Design: The Future of Excipients" on May 13 from 2:00 to 2:45 p.m. ET. The session will take place in the Riverview Ballroom, Stage 2, and will cover how IFF integrates sustainability into every aspect of excipient manufacturing.
With over 75 years of experience, IFF Pharma Solutions continues to lead in sustainable healthcare, emphasizing innovation and responsibility towards creating a healthier future.
